In contrast, HOXA13, HOXC6, HOXB7, HOXA1, HOXC9, HOXC10, HOXD4, HOXA11 and HOXD9 were expressed at high levels and functioned as tumour promotors in patients with GC. This evidence concerns the gene HOXA13 and neoplasm.